Could Acadia use the p1 results from Neuren for Fragike X though - it would make sense from a safety perspective, but if that was the case then Neuren wouldn’t need to run any additional p1 trials fir the 3 additional indications they are running now, unless the dosage is different, but I don’t think it is…
Could Acadia use the p1 results from Neuren for Fragike X though...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.43 |
Change
-0.560(2.80%) |
Mkt cap ! $2.505B | |||
| Open | High | Low | Value | Volume |
| $20.10 | $20.10 | $19.40 | $2.998M | 153.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 524 | $19.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.44 | 418 | 13 |
View Market Depth
| Last trade - 13.00pm 09/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |